Dextromethorphan
Rett Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Rett Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HEPTANOIN, TRI- Center for Rare Neurological Diseases, Norcross, GA | Phase 2 | CCC |
Topamax Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A | D |
Same molecule, other indications
Dextromethorphan is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →